StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) stock

QNRXNasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.56+0.20 (+5.95%)

Close on Nov 18, 2026Market cap $7.15MP/E –Yield –

Quoin Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Quoin Pharmaceuticals

Quoin Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Quoin Pharmaceuticals figures

See a number that looks wrong?